News

As infections in the U.S. continue to be at high levels, the Food and Drug Administration on 13th July approved a fourth vaccination for COVID-19 prevention, authorising Novavax's coronavirus jab for emergency use in adults. The Maryland-based drugmaker's early results on...

When the epidemic subsides, Alkem Laboratories predicts that inflationary pressures and shifting regulatory standards will be the primary concerns to keep an eye on, and that normal business operations would allow the Indian pharmaceutical industry to resume its 8–11%...

Sharp, a global leader in contract packaging and clinical supply services, has formed a strategic partnership with China-based ClinsChain to expand its reach and capabilities into the Chinese market. Sharp will collaborate with ClinsChain - who specialize in providing clinical...

Lonza, a major CDMO, is to invest $518 million in a new, massive fill-finish manufacturing facility in Stein, Switzerland. According to the firm, the facility will use sustainable construction methods to lower carbon emissions when it is finished in...

Pfizer and another pharmaceutical major, Touchlight, have come to a deal on a significant non-exclusive patent licence. Touchlight is a firm that focuses on enzymatic DNA manufacturing to further enhance genetic therapies. As a result of the licencing arrangement, Pfizer...

The standard response to any poor performance is to blame the supply chain, which has almost attained the status of a joke. However, it is now one of a serious group of interconnected economic headwinds that also includes the...

On July 6, the US Food and Drug Administration modified the COVID-19 antiviral drug Paxlovid's emergency use authorization to permit state-licensed pharmacists to recommend the medication to those who qualify. Dr. Patrizia Cavazzoni, head of the FDA's Center for Drug Evaluation...